Cargando…
Neurone specific enolase (NSE) in small cell lung cancer: a tumour marker of prognostic significance?
Pretreatment serum levels of neurone specific enolase (NSE) were measured in patients with small cell lung cancer (SCLC). Median values were significantly higher in patients with extensive compared with limited stage disease (48 ng ml-1 v. 17 ng ml-1: P less than 0.001). Serial NSE levels paralleled...
Autores principales: | Harding, M., McAllister, J., Hulks, G., Vernon, D., Monie, R., Paul, J., Kaye, S. B. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1990
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1971357/ https://www.ncbi.nlm.nih.gov/pubmed/2158809 |
Ejemplares similares
-
Ca125 and neuron-specific enolase (NSE) as tumour markers for intra-abdominal desmoplastic small round-cell tumours.
por: Fizazi, K., et al.
Publicado: (1997) -
GFAP and Neuron Specific Enolase (NSE) in the Serum of Suicide Attempters
por: Bagheri, Maryam, et al.
Publicado: (2022) -
Serum neuron-specific enolase (S-NSE) in progressive small-cell lung cancer (SCLC).
por: Jørgensen, L. G., et al.
Publicado: (1994) -
Enhanced Expression of Neuron‐specific Enolase (NSE) in Pyothorax‐associated Lymphoma (PAL)
por: Nakatsuka, Shin‐ichi, et al.
Publicado: (2002) -
Neuron-Specific Enolase (NSE) as a Biomarker for Autistic Spectrum Disease (ASD)
por: Stancioiu, Felician, et al.
Publicado: (2023)